CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income/(Loss)
Balance, shares (in shares) at Mar. 30, 2019			51,020
Balance, value at Mar. 30, 2019	$ 667,868		$ 510	$ 536,320		$ 161,418		$ (30,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			45
Employee stock purchase plan	3,369		$ 1	3,368
Exercise of stock options (in shares)			232
Exercise of stock options	8,647		$ 2	8,645
Shares repurchased (in shares)			(1,483)
Shares repurchased	(175,000)		$ (15)	(15,553)		(159,432)
Issuance of restricted stock, net of cancellations (in shares)			509
Issuance of restricted stock, net of cancellations	0		$ 5	(5)
Share-based compensation expense	20,454			20,454
Net income	76,526					76,526
Other comprehensive income (loss)	(14,755)							(14,755)
Balance, shares (in shares) at Mar. 28, 2020			50,323
Balance, value at Mar. 28, 2020	587,109		$ 503	553,229		78,512		(45,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			44
Employee stock purchase plan	4,013		$ 1	4,012
Exercise of stock options (in shares)			128
Exercise of stock options	6,219		$ 1	6,218
Issuance of restricted stock, net of cancellations (in shares)			374
Issuance of restricted stock, net of cancellations	0		$ 4	(4)
Share-based compensation expense	25,516			25,516
Equity component of convertible notes, net of issuance costs	61,156			61,156
Purchase of capped call related to convertible notes	(47,400)			(47,400)
Net income	79,469					79,469
Other comprehensive income (loss)	15,588							15,588
Balance, shares (in shares) at Apr. 03, 2021			50,869
Balance, value at Apr. 03, 2021	731,670	$ (60,121)	$ 509	602,727	$ (61,156)	157,981	$ 1,035	(29,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			74
Employee stock purchase plan	4,209		$ 0	4,209
Exercise of stock options (in shares)			66
Exercise of stock options	2,338		$ 1	2,337
Issuance of restricted stock, net of cancellations (in shares)			115
Issuance of restricted stock, net of cancellations	1		$ 1	0
Share-based compensation expense	24,359			24,359
Net income	43,375					43,375
Other comprehensive income (loss)	3,593							3,593
Balance, shares (in shares) at Apr. 02, 2022			51,124
Balance, value at Apr. 02, 2022	$ 749,424		$ 511	$ 572,476		$ 202,391		$ (25,954)